Curium Completes Patient Enrollment o... - Advanced Prostate...
Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule (177 Lu-PSMA I&T)
Written by
Maxone73
To view profiles and participate in discussions please or .
1 Reply
•
This means this drug will become very expensive too.
Not what you're looking for?
You may also like...
Phase 3 trial 177-Lu-PSMA-617
Is anyone in the in the Phase 3 trial going on at UCSF & Stanford that started in 2018 that will...
Eclipse Trial Update - Lutetium-Lu 177
Just received lab results from my 2nd dose of Lu177, 2 weeks ago. My PSA dropped from 2.0 to 0.3....
177 LU-PSMA-617 Phase 3 trial starting in 2018
Here's an article regarding a phase 3 trial starting in 2018. This might be old news for some, but...
Discussion of Phase 2 trial with LU-177 PSMA-617
I saw this presentation of the results of a phase 2 trial with LU-177 PSMA-617 and thought it was...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of...
Related Posts
Update On Eclipse Trial-another failure. Has LU-177 worked for anyone?
PET/PSMA scan results after 3rd LU-177. Should I go ahead with SBRT or complete 4th LU-177?
Lu-177 clinical trial university of Chicago 
New Phase 1b (NON-randomized, dose timing) trial of Lu-177-PSMA-617 + Keytruda at UCSF announced- Lu-177-PSMA-617 VISION trial suspended temporarily for new recruiting
